Please wait while the formulary information is being retrieved.
XEOMIN (INCOBOTULINUMTOXINA)
- Blepharospasm
- Glabellar lines
- Spasmodic torticollis
- Sialorrhea
- Upper limb spasticity
100 unit intramuscular solution
- Dosage information is not available
200 unit intramuscular solution
- Dosage information is not available
50 unit intramuscular solution
- Dosage information is not available
- None
Contraindicated
- Adoxa
- amikacin
- Avidoxy
- Compound 347
- demeclocycline
- dextromethorphan-quinidine
- Doryx
- Doxy-100
- doxycycline calcium
- doxycycline hyclate
- doxycycline monohydrate
- enflurane
- Forane
- gentamicin
- gentamicin in NaCl (iso-osm)
- gentamicin sulfate (ped) (PF)
- gentamicin sulfate (PF)
- isoflurane
- Minocin
- minocycline
- Monodox
- Morgidox
- neomycin
- Nuedexta
- Oracea
- paromomycin
- Qualaquin
- quinidine gluconate
- quinidine sulfate
- quinine sulfate
- sevoflurane
- Sojourn
- Solodyn
- streptomycin
- Terrell
- tetracycline
- tigecycline
- tobramycin in 0.9 % NaCl
- tobramycin sulfate
- Tygacil
- Ultane
- Vibramycin
Severe
Moderate
- Acanya
- Baciim
- bacitracin
- Benzaclin
- Benzaclin Pump
- Capastat
- capreomycin
- Cerebyx
- Cleocin
- Cleocin In 5 % Dextrose
- Cleocin T
- Clindacin Etz
- Clindacin P
- Clindacin Pac
- Clindagel
- clindamycin HCl
- clindamycin in dextrose 5%
- clindamycin palmitate HCl
- Clindamycin Pediatric
- clindamycin phos-skin clnsr 19
- clindamycin phosphate
- clindamycin-benzoyl peroxide
- clindamycin-tretinoin
- Clindesse
- colistin (colistimethate Na)
- Coly-mycin M Parenteral
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Duac
- ethotoin
- Evoclin
- fosphenytoin
- Lincocin
- lincomycin
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- polymyxin B sulfate
- vancomycin
- vancomycin in D5W
- vancomycin in dextrose iso-osm
- Veltin
- Ziana
- Dysphagia
- Dyspnea
- Respiratory depression
Contraindicated
- Amyotrophic lateral sclerosis
- Blepharoptosis
- Blurred vision
- Botulism
- Cerebral palsy-associated limb spasticity
- Dysarthria
- Eaton-lambert syndrome
- Muscle spasticity of cerebral origin
- Muscle spasticity of spinal origin
- Muscle weakness
- Myasthenia gravis
- Peripheral motor neuropathy
- Polyopia
- Urinary incontinence
Severe
Moderate
- Predisposition to aspiration
XEOMIN (INCOBOTULINUMTOXINA)
- Blepharospasm
- Glabellar lines
- Spasmodic torticollis
- Sialorrhea
- Upper limb spasticity
- Dysphagia
- Dyspnea
- Hypertension
- Lagophthalmos
- Muscle weakness
- Seizure disorder
- Blepharoptosis
- Diarrhea
- Dry eye
- Headache disorder
- Injection site sequelae
- Neck pain
- Pharyngitis
- Upper respiratory infection
- Xerostomia
More Frequent
Severe
Less Severe
- Diplopia
- Infection
- Allergic dermatitis
- Disorder of the digestive system
- Ecchymosis
- Eyelid edema
- Musculoskeletal pain
- Nausea
- Pruritus of skin
- Skin rash
- Visual changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Accidental fall
- Acute respiratory distress syndrome
- Blinking decreased
- Bronchitis
- Dysarthria
- Ectropion
- General weakness
- Hypersensitivity drug reaction
- Myalgias
- Respiration changes
- Urinary incontinence
- Voice change
Less Severe
- Back pain
- Blurred vision
- Edema
- Erythema
- Flu-like symptoms
- Herpes zoster
- Muscle spasm
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
IncobotulinumtoxinA
Safety and efficacy not established. Not recommended age <18 years.
- 1 Day – 18 Years
- Safety and efficacy not established. Not recommended age <18 years.
Incobotulinumtoxina
- Severity Level:
2
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Incobotulinum Toxin A
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- See also Uses section. This medication can spread to other parts of the body after your injection, causing serious (possibly fatal) side effects. These can occur hours or even weeks after the injection.<br /><br />However, the chances of such serious side effects occurring when this medication is used for migraines or skin conditions such as wrinkles, eye spasm, or excessive sweating are extremely unlikely. Children being treated for muscle stiffness/spasms have the greatest risk of these effects, as well as anyone that has certain medical conditions (see Precautions section). Discuss the risks and benefits of this medication with your doctor. Get medical help right away if any of these very serious side effects occur: chest pain, difficulty breathing, excessive muscle weakness, irregular heartbeat, severe difficulty swallowing or speaking, loss of bladder control.
| Blepharospasm | |
| G24.5 | Blepharospasm |
| Glabellar lines | |
| L98.8 | Other specified disorders of the skin and subcutaneous tissue |
| Sialorrhea | |
| K11.7 | Disturbances of salivary secretion |
| Spasmodic torticollis | |
| G24.3 | Spasmodic torticollis |
| Upper limb spasticity | |
| G04.1 | Tropical spastic paraplegia |
| G11.4 | Hereditary spastic paraplegia |
| G80.0 | Spastic quadriplegic cerebral palsy |
| G80.1 | Spastic diplegic cerebral palsy |
| G80.2 | Spastic hemiplegic cerebral palsy |
| G81.1 | Spastic hemiplegia |
| G81.10 | Spastic hemiplegia affecting unspecified side |
| G81.11 | Spastic hemiplegia affecting right dominant side |
| G81.12 | Spastic hemiplegia affecting left dominant side |
| G81.13 | Spastic hemiplegia affecting right nondominant side |
| G81.14 | Spastic hemiplegia affecting left nondominant side |
| M62.838 | Other muscle spasm |
| 0-9 | A-Z |
|---|---|
| G04.1 | Tropical spastic paraplegia |
| G11.4 | Hereditary spastic paraplegia |
| G24.3 | Spasmodic torticollis |
| G24.5 | Blepharospasm |
| G80.0 | Spastic quadriplegic cerebral palsy |
| G80.1 | Spastic diplegic cerebral palsy |
| G80.2 | Spastic hemiplegic cerebral palsy |
| G81.1 | Spastic hemiplegia |
| G81.10 | Spastic hemiplegia affecting unspecified side |
| G81.11 | Spastic hemiplegia affecting right dominant side |
| G81.12 | Spastic hemiplegia affecting left dominant side |
| G81.13 | Spastic hemiplegia affecting right nondominant side |
| G81.14 | Spastic hemiplegia affecting left nondominant side |
| K11.7 | Disturbances of salivary secretion |
| L98.8 | Other specified disorders of the skin and subcutaneous tissue |
| M62.838 | Other muscle spasm |
Formulary Reference Tool